Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ursodiol for Recurrent C. Difficile Colitis
NCT02748616Phase 4Completed
- Sponsor
- NYU Langone Health
- Start
- Mar 2017
- Primary completion
- Nov 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of ursodeoxycholic acid in Clostridioides difficile infection (CDI), sponsored by NYU Langone Health. Started Mar 2017; status: completed.
02
Drugs
ursodeoxycholic acid
03
Conditions
Clostridioides difficile infection (CDI)
Beyond the preview
Go deeper on NCT02748616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02748616.